Tim Read
About Tim Read
Tim Read CTO and Co-founder
Tim Read serves as the Chief Technology Officer (CTO) and Co-founder of the company. In his role, he directs the company's technological advancements and innovations. As a co-founder, he has played a crucial part in shaping the company's strategic vision and operational framework. His leadership is central to the development and implementation of advanced technologies that drive the company's core objectives.
PhD in Molecular Biology University of Colorado
Tim Read received his PhD in Molecular Biology from the University of Colorado. During his doctoral studies, he focused on understanding the mechanisms of eukaryotic transcription. His research provided significant insights into the transcription processes in eukaryotic cells, contributing to the broader field of molecular biology.
Postdoctoral Fellowship at Harvard Medical School
Tim Read completed his postdoctoral fellowship at Harvard Medical School, further honing his expertise in molecular biology. The fellowship offered him advanced training and research opportunities, allowing him to expand his knowledge and contribute to important scientific discoveries. This experience has equipped him with a deep understanding of complex biological processes, which he applies in his current role.
Transcriptomic Drug Screening Efforts
As the leader of the company's transcriptomic drug screening efforts, Tim Read oversees the identification and development of new therapeutic targets using transcriptomics. His work involves leveraging transcriptomic data to enhance drug discovery processes. By focusing on the transcriptomic profile of diseases, he aims to identify critical gene expression patterns that can be targeted for therapeutic intervention.